153 related articles for article (PubMed ID: 28978143)
1. Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.
Truini A; Coco S; Nadal E; Genova C; Mora M; Dal Bello MG; Vanni I; Alama A; Rijavec E; Biello F; Barletta G; Merlo DF; Valentino A; Ferro P; Ravetti GL; Stigliani S; Vigani A; Fedeli F; Beer DG; Roncella S; Grossi F
Oncotarget; 2017 Sep; 8(40):68627-68640. PubMed ID: 28978143
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide screen identified let-7c/miR-99a/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma.
Lin KY; Ye H; Han BW; Wang WT; Wei PP; He B; Li XJ; Chen YQ
Oncogene; 2016 Jun; 35(26):3376-86. PubMed ID: 26455324
[TBL] [Abstract][Full Text] [Related]
3. Slow Transcription of the 99a/let-7c/125b-2 Cluster Results in Differential MiRNA Expression and Promotes Melanoma Phenotypic Plasticity.
Sheinboim D; Parikh S; Parikh R; Menuchin A; Shapira G; Kapitansky O; Elkoshi N; Ruppo S; Shaham L; Golan T; Elgavish S; Nevo Y; Bell RE; Malcov-Brog H; Shomron N; Taub JW; Izraeli S; Levy C
J Invest Dermatol; 2021 Dec; 141(12):2944-2956.e6. PubMed ID: 34186058
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism.
De Santi C; Melaiu O; Bonotti A; Cascione L; Di Leva G; Foddis R; Cristaudo A; Lucchi M; Mora M; Truini A; Tironi A; Murer B; Boldorini R; Cipollini M; Gemignani F; Gasparini P; Mutti L; Landi S
Sci Rep; 2017 Jun; 7(1):3140. PubMed ID: 28600498
[TBL] [Abstract][Full Text] [Related]
5. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.
Sun D; Layer R; Mueller AC; Cichewicz MA; Negishi M; Paschal BM; Dutta A
Oncogene; 2014 Mar; 33(11):1448-57. PubMed ID: 23503464
[TBL] [Abstract][Full Text] [Related]
6. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
[TBL] [Abstract][Full Text] [Related]
7. MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma.
Kirschner MB; Cheng YY; Armstrong NJ; Lin RC; Kao SC; Linton A; Klebe S; McCaughan BC; van Zandwijk N; Reid G
Mol Oncol; 2015 Mar; 9(3):715-26. PubMed ID: 25497279
[TBL] [Abstract][Full Text] [Related]
8. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA signature in metastatic colorectal cancer patients treated with anti-EGFR monoclonal antibodies.
Cappuzzo F; Sacconi A; Landi L; Ludovini V; Biagioni F; D'Incecco A; Capodanno A; Salvini J; Corgna E; Cupini S; Barbara C; Fontanini G; Crinò L; Blandino G
Clin Colorectal Cancer; 2014 Mar; 13(1):37-45.e4. PubMed ID: 24503111
[TBL] [Abstract][Full Text] [Related]
10. BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.
Murrone A; Cantini L; Pecci F; Cognigni V; Copparoni C; Rinaldi S; Fiordoliva I; Monaco F; Rubini C; Barbisan F; Cimadamore A; Giampieri R; Bianchi F; Tomasetti M; Amati M; Santarelli L; Berardi R
J Thorac Dis; 2021 Oct; 13(10):5741-5751. PubMed ID: 34795923
[TBL] [Abstract][Full Text] [Related]
11. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs dysregulation in human malignant pleural mesothelioma.
Balatti V; Maniero S; Ferracin M; Veronese A; Negrini M; Ferrocci G; Martini F; Tognon MG
J Thorac Oncol; 2011 May; 6(5):844-51. PubMed ID: 21358347
[TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated epigenetic silencing of tumor-suppressive let-7c/miR-99a cluster by hepatitis B virus X antigen enhances hepatocellular carcinoma progression and metastasis.
Cancer Cell Int; ; . PubMed ID: 37689710
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
